Credit Agricole’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $786K | Sell |
7,109
-438
| -6% | -$48.4K | ﹤0.01% | 864 |
|
|
2024
Q4 | $1.03M | Buy |
7,547
+947
| +14% | +$129K | ﹤0.01% | 821 |
|
|
2024
Q3 | $760K | Sell |
6,600
-7,006
| -51% | -$807K | ﹤0.01% | 771 |
|
|
2024
Q2 | $1.87M | Buy |
13,606
+6,400
| +89% | +$881K | 0.01% | 522 |
|
|
2024
Q1 | $955K | Buy |
+7,206
| New | +$955K | 0.01% | 484 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$49K | – | 642 |
|
|
2021
Q2 | $49K | Hold |
500
| – | – | ﹤0.01% | 444 |
|
|
2021
Q1 | $49K | Buy |
+500
| New | +$49K | ﹤0.01% | 407 |
|
|
2017
Q4 | – | Sell |
-1,000
| Closed | -$61K | – | 821 |
|
|
2017
Q3 | $61K | Hold |
1,000
| – | – | ﹤0.01% | 1382 |
|
|
2017
Q2 | $46K | Buy |
+1,000
| New | +$46K | ﹤0.01% | 1383 |
|
|
2016
Q4 | – | Sell |
-2,792
| Closed | -$141K | – | 1490 |
|
|
2016
Q3 | $141K | Buy |
+2,792
| New | +$141K | ﹤0.01% | 1435 |
|